Center will expand research infrastructure, strengthen international scientific cooperation, and drive the development of vaccines, diagnostics, and new therapies over the next five years.
The Institut Pasteur de São Paulo (IPSP) is entering a new phase of scientific expansion with the approval of the International Center Institut Pasteur de São Paulo (CIP-IPSP). With an investment of approximately BRL 15 million over the next five years, the initiative is funded by the São Paulo Research Foundation (FAPESP) and consolidates the strategic partnership between the University of São Paulo (USP), the Institut Pasteur in Paris, and the Pasteur Network. The project will expand the institution’s research infrastructure, strengthen international scientific cooperation, and create new opportunities for Brazilian and international researchers to develop high-impact health projects.
The CIP-IPSP represents the second phase of IPSP’s development and was designed to expand the institute’s scientific and technological capacity through the creation of new technological platforms, the attraction of researchers and visiting professors, and the strengthening of international research networks. The initiative will bring together complementary expertise to address global health challenges, including emerging and re-emerging infectious diseases, neurosciences, translational medicine, biodiversity, and the impacts of environmental changes on human, animal, and environmental health.
Among the planned actions are the implementation of four new technological research platforms focused on flow cytometry and imaging, recombinant protein production, structural biology and crystallography, as well as the strengthening of strategic biological collections. The project will also expand IPSP’s scientific infrastructure, attract new fellows and highly qualified technical staff, researchers and visiting professors from Brazil and abroad, and create new opportunities for scientists from USP and other national and international institutions to join the center.
“This approval represents the recognition of a collective scientific effort that has been developed over many years. The International Center will enable us to expand our research capacity, attract talent, and strengthen collaboration between Brazilian and international scientists to address some of the greatest challenges in global health,” said Paola Minoprio, Executive Director of IPSP.
According to her, the new structure will help accelerate the transformation of scientific knowledge into tangible benefits for society.
“Our goal is to create an increasingly integrated and international environment capable of connecting basic research, technological innovation, and public health applications. The CIP-IPSP will expand opportunities for the development of vaccines, diagnostics, therapies, and other innovative solutions that can generate a real impact on people’s lives,” she added.
Based on the One Health concept, the center will promote an integrated approach that considers the interactions between human, animal, and environmental health. The initiative also reinforces Brazil’s role as one of the world’s most strategic environments for research in biodiversity, infectious diseases, climate change, and biomedical innovation.
With the approval of CIP-IPSP, the Institut Pasteur de São Paulo takes another step forward in its mission to consolidate an international hub of scientific excellence capable of generating knowledge, training highly qualified human resources, and contributing to the development of solutions for the health challenges of the 21st century.